These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24583005)

  • 21. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
    Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
    Kamili S; Spelbring J; Carson D; Krawczynski K
    J Infect Dis; 2004 Jan; 189(2):258-64. PubMed ID: 14722891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells.
    Qi Y; Fan J; Huang W; Zhao C; Wang Y; Kong FT; Kong W; Jiang C
    Biotechnol Appl Biochem; 2016 May; 63(3):362-70. PubMed ID: 25824972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells.
    Liu S; Li J; Peraramelli S; Luo N; Chen A; Dai M; Liu F; Yu Y; Leib RD; Li Y; Lin K; Huynh D; Li S; Ou L
    Mol Ther; 2024 Jan; 32(1):74-83. PubMed ID: 37990495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector.
    Maurer L; El Andari J; Rapti K; Spreyer L; Steinmann E; Grimm D; Dao Thi VL
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient production of an avian adeno-associated virus vector using insect cell/baculovirus expression system.
    Wang A; Wang Y; Wu S; Zuo W; Guo C; Hong W; Zhu S
    J Virol Methods; 2017 Feb; 240():26-31. PubMed ID: 27867046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live recombinant Lactococcuslactis expressing avian hepatitis virus ORF2 protein: Immunoprotection against homologous virus challenge in chickens.
    Wang D; Zhang Y; Ma C; Ma D; Zhao Q; Wang F; Huang Y; Li J; Zhang L; Zhou EM
    Vaccine; 2018 Feb; 36(8):1108-1115. PubMed ID: 29406242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis E vaccine development: a 14 year odyssey.
    Wu T; Li SW; Zhang J; Ng MH; Xia NS; Zhao Q
    Hum Vaccin Immunother; 2012 Jun; 8(6):823-7. PubMed ID: 22699438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis E: an overview and recent advances in vaccine research.
    Wang L; Zhuang H
    World J Gastroenterol; 2004 Aug; 10(15):2157-62. PubMed ID: 15259057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production.
    Wu Y; Mei T; Jiang L; Han Z; Dong R; Yang T; Xu F
    Hum Gene Ther Methods; 2019 Oct; 30(5):172-183. PubMed ID: 31566024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Head-to-Head Evaluation of Recombinant Adeno-associated Viral Vectors Manufactured in Human versus Insect Cells.
    Kondratov O; Marsic D; Crosson SM; Mendez-Gomez HR; Moskalenko O; Mietzsch M; Heilbronn R; Allison JR; Green KB; Agbandje-McKenna M; Zolotukhin S
    Mol Ther; 2017 Dec; 25(12):2661-2675. PubMed ID: 28890324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.
    Zhang M; Emerson SU; Nguyen H; Engle RE; Govindarajan S; Gerin JL; Purcell RH
    Vaccine; 2001 Dec; 20(5-6):853-7. PubMed ID: 11738749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rapid and efficient expression of foreign genes in mammalian cells by baculovirus vectors].
    Cheng T; Xu CY; Wang YB; Chen M; Wu T; Xie XY; Zhang J; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):581-6. PubMed ID: 15969088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of hepatitis E virus ORF3 gene fragment in baculovirus system and its immunological character].
    Du RJ; Ma YB; Tang H; Zhuang JY; Le GY; Liu Y; Dai CB; Sun MS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):378-81. PubMed ID: 12940081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designing, Construction and Expression of a Recombinant Fusion Protein Comprising the Hepatitis E Virus ORF2 and Rotavirus NSP4 in the Baculovirus Expression System.
    Makvandi M; Teimoori A; Neisi N; Samarbafzadeh A
    Jundishapur J Microbiol; 2016 Nov; 9(11):e40303. PubMed ID: 28138375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases.
    Galibert L; Merten OW
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S80-93. PubMed ID: 21784234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in creating a vaccine to prevent hepatitis E.
    Maloney BJ; Takeda N; Suzaki Y; Ami Y; Li TC; Miyamura T; Arntzen CJ; Mason HS
    Vaccine; 2005 Mar; 23(15):1870-4. PubMed ID: 15734058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV].
    Bi S; Lu J; Jiang L; Huang G; Pan H; Jiang Y; Zhang M; Shen X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):31-2. PubMed ID: 11986741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.